CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank58
3Y CAGR+37.4%
5Y CAGR-29.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+37.4%/yr
vs -28.2%/yr prior
5Y CAGR
-29.3%/yr
Recent acceleration
Acceleration
+65.5pp
Accelerating
Percentile
P58
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.23M | -26.3% |
| 2024 | $7.10M | -27.6% |
| 2023 | $9.81M | +386.0% |
| 2022 | $2.02M | +1073.3% |
| 2021 | $172000.00 | -99.4% |
| 2020 | $29.63M | +260.0% |
| 2019 | $8.23M | +8.7% |
| 2018 | $7.57M | +186.1% |
| 2017 | $2.65M | +296.9% |
| 2016 | $667000.00 | - |